Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.82 USD | +0.68% |
|
+15.45% | +4.63% |
06-24 | Replimune Group, Inc.(NasdaqGS:REPL) dropped from S&P Biotechnology Select Industry Index | CI |
06-13 | Replimune Group Signs $100 Million PIPE Deal with Institutional Investors | MT |
Evolution of the average Target Price on Replimune Group, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
![Consensus](/images/consensus_flch.gif)
Consensus detail
Consensus revision (last 18 months)
Analysts covering Replimune Group, Inc.
HC Wainwright | |
Wedbush | |
Barclays | |
JPMorgan Chase | |
Piper Sandler | |
EF Hutton | |
BMO Capital | |
SVB Securities LLC | |
SVB Leerink | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- REPL Stock
- Consensus Replimune Group, Inc.